Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 110

Related Citations for PubMed (Select 24449391)

1.

Concise review: Defining and targeting myeloma stem cell-like cells.

Abe M, Harada T, Matsumoto T.

Stem Cells. 2014 May;32(5):1067-73. doi: 10.1002/stem.1643. Review.

PMID:
24449391
2.

The search for multiple myeloma stem cells: the long and winding road.

Basak GW, Carrier E.

Biol Blood Marrow Transplant. 2010 May;16(5):587-94. doi: 10.1016/j.bbmt.2009.10.024. Epub 2009 Nov 4. Review.

PMID:
19895894
3.

Identify multiple myeloma stem cells: Utopia?

Saltarella I, Lamanuzzi A, Reale A, Vacca A, Ria R.

World J Stem Cells. 2015 Jan 26;7(1):84-95. doi: 10.4252/wjsc.v7.i1.84. Review.

4.

Multiple myeloma: a paradigm for translation of the cancer stem cell hypothesis.

Agarwal JR, Matsui W.

Anticancer Agents Med Chem. 2010 Feb;10(2):116-20. Review.

5.

Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance.

Matsui W, Wang Q, Barber JP, Brennan S, Smith BD, Borrello I, McNiece I, Lin L, Ambinder RF, Peacock C, Watkins DN, Huff CA, Jones RJ.

Cancer Res. 2008 Jan 1;68(1):190-7. doi: 10.1158/0008-5472.CAN-07-3096.

6.

Telomerase inhibition targets clonogenic multiple myeloma cells through telomere length-dependent and independent mechanisms.

Brennan SK, Wang Q, Tressler R, Harley C, Go N, Bassett E, Huff CA, Jones RJ, Matsui W.

PLoS One. 2010 Sep 1;5(9). pii: e12487. doi: 10.1371/journal.pone.0012487.

7.

Fact or fiction--identifying the elusive multiple myeloma stem cell.

Kellner J, Liu B, Kang Y, Li Z.

J Hematol Oncol. 2013 Dec 7;6:91. doi: 10.1186/1756-8722-6-91. Review.

8.

Concise review: breast cancer stem cells: regulatory networks, stem cell niches, and disease relevance.

Guo W.

Stem Cells Transl Med. 2014 Aug;3(8):942-8. doi: 10.5966/sctm.2014-0020. Epub 2014 Jun 5. Review.

PMID:
24904174
9.

Drug resistance in multiple myeloma: novel therapeutic targets within the malignant clone.

Pilarski LM, Mant MJ, Belch AR.

Leuk Lymphoma. 1999 Jan;32(3-4):199-210. Review.

PMID:
10037018
10.

Cancer stem cells and angiogenesis.

Zhao Y, Bao Q, Renner A, Camaj P, Eichhorn M, Ischenko I, Angele M, Kleespies A, Jauch KW, Bruns C.

Int J Dev Biol. 2011;55(4-5):477-82. doi: 10.1387/ijdb.103225yz. Review.

11.

Clonogenic multiple myeloma cells have shared stemness signature associated with patient survival.

Reghunathan R, Bi C, Liu SC, Loong KT, Chung TH, Huang G, Chng WJ.

Oncotarget. 2013 Aug;4(8):1230-40.

12.

Myeloma stem cell concepts, heterogeneity and plasticity of multiple myeloma.

Hajek R, Okubote SA, Svachova H.

Br J Haematol. 2013 Dec;163(5):551-64. doi: 10.1111/bjh.12563. Epub 2013 Sep 20. Review.

PMID:
24111932
13.

Cancer stem cell dynamics in tumor progression and metastasis: is the microenvironment to blame?

Fessler E, Dijkgraaf FE, De Sousa E Melo F, Medema JP.

Cancer Lett. 2013 Nov 28;341(1):97-104. doi: 10.1016/j.canlet.2012.10.015. Epub 2012 Oct 23. Review.

PMID:
23089245
14.

Cancer stem cells in multiple myeloma.

Ghosh N, Matsui W.

Cancer Lett. 2009 May 8;277(1):1-7. doi: 10.1016/j.canlet.2008.08.005. Epub 2008 Sep 21. Review.

15.

Cancer stem cells and the tumor microenvironment: soloists or choral singers.

Albini A, Cesana E, Noonan DM.

Curr Pharm Biotechnol. 2011 Feb 1;12(2):171-81. Review.

PMID:
21044010
16.

Single-cell clones of liver cancer stem cells have the potential of differentiating into different types of tumor cells.

Liu H, Zhang W, Jia Y, Yu Q, Grau GE, Peng L, Ran Y, Yang Z, Deng H, Lou J.

Cell Death Dis. 2013 Oct 17;4:e857. doi: 10.1038/cddis.2013.340.

17.

A 3D multiscale model of cancer stem cell in tumor development.

Li F, Tan H, Singh J, Yang J, Xia X, Bao J, Ma J, Zhan M, Wong ST.

BMC Syst Biol. 2013;7 Suppl 2:S12. doi: 10.1186/1752-0509-7-S2-S12. Epub 2013 Dec 17.

18.

Cancer stem cell niche: the place to be.

Borovski T, De Sousa E Melo F, Vermeulen L, Medema JP.

Cancer Res. 2011 Feb 1;71(3):634-9. doi: 10.1158/0008-5472.CAN-10-3220. Epub 2011 Jan 25. Review.

19.

CD20 positive cells are undetectable in the majority of multiple myeloma cell lines and are not associated with a cancer stem cell phenotype.

Paíno T, Ocio EM, Paiva B, San-Segundo L, Garayoa M, Gutiérrez NC, Sarasquete ME, Pandiella A, Orfao A, San Miguel JF.

Haematologica. 2012 Jul;97(7):1110-4. doi: 10.3324/haematol.2011.057372. Epub 2012 Feb 7.

20.

Identification of a stem-like cell population by exposing metastatic breast cancer cell lines to repetitive cycles of hypoxia and reoxygenation.

Louie E, Nik S, Chen JS, Schmidt M, Song B, Pacson C, Chen XF, Park S, Ju J, Chen EI.

Breast Cancer Res. 2010;12(6):R94. doi: 10.1186/bcr2773. Epub 2010 Nov 10.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk